1 insiders reported 6 Form 4 transactions for Oncotelic Therapeutics, Inc. (OTLC) over the past 18 months (most recent 2025-07-10). Recent activity: Trieu Vuong (CHAIRMAN AND CEO) Buy 1 shares, Trieu Vuong (CHAIRMAN AND CEO) Buy 94,736 shares, Trieu Vuong (CHAIRMAN AND CEO) Buy 104,000 shares, Trieu Vuong (CHAIRMAN AND CEO) Buy 183,066 shares, Trieu Vuong (CHAIRMAN AND CEO) Buy 100,003 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-10 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 1 | $0 |
| 2025-07-10 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 94,736 | $947 |
| 2025-07-10 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 104,000 | $1,040 |
| 2025-01-31 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 183,066 | $5,492 |
| 2025-01-31 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 100,003 | $3,000 |
| 2025-01-31 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 63,775 | $1,913 |
Source: SEC Form 4 filings · as of 2025-07-10